They also suggest that serum levels of inflammatory biomarkers (primarily IL-1β, IL-6, TNF-α, and hs-CRP) in depressed patients are useful biomarkers that can be used in combination with the assessment of depression scores. Here, IL1B is linked to depressive symptom measurement.